124I-βCIT is a new radiopharmaceutical compound for neurodegenerative disorder diagnosis with PET imaging. It is an analogue of cocaine and binds dopamine and serotonin transporters. Neurodegenerative disorders, such as Parkinson’s disease, are characterized by degeneration of dopaminergic neurons in the substantia nigra, with loss of their nerve terminals in the basal ganglia structure, especially in the striatum.

If you want try it in a clinical trial contact us by community. An interesting case report showed in reserved area, suggest a specific binding with melanoma brain metastasis.

If you want read it, please joint in to free Acom community

Acom Group